Literature DB >> 7227176

Electrodiagnostics of the tilted disc syndrome.

R Wijngaarde, G H van Lith.   

Abstract

In five patients with a tilted disc syndrome the visually evoke potentials were examined by means of pattern stimulation. It was hoped that by such an examination this syndrome could be distinguished from a chiasma syndrome, since it is known that compression of the anterior visual pathways causes delayed responses, whereas defects or atrophies generally do not. In 4 patients, however, delayed responses were found and they were not found in only one patient.

Entities:  

Mesh:

Year:  1981        PMID: 7227176     DOI: 10.1007/bf00158021

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  5 in total

1.  The pattern-evoked potential in compression of the anterior visual pathways.

Authors:  A M Halliday; E Halliday; A Kriss; W I McDonald; J Mushin
Journal:  Brain       Date:  1976-06       Impact factor: 13.501

2.  Visual evoked response in diagnosis of multiple sclerosis.

Authors:  A M Halliday; W I McDonald; J Mushin
Journal:  Br Med J       Date:  1973-12-15

3.  [Bitemporal and binasal hemianopsia].

Authors:  A T van Balen
Journal:  Ned Tijdschr Geneeskd       Date:  1972-07-15

4.  Differences between the occipital distribution of upper and lower field pattern-evoked responses in man.

Authors:  W F Michael; A M Halliday
Journal:  Brain Res       Date:  1971-09-24       Impact factor: 3.252

5.  Value of pattern evoked cortical potentials for the diagnosis of multiple sclerosis.

Authors:  G H van Lith; A G van Vliet; G T van Dok-Mak
Journal:  Doc Ophthalmol       Date:  1979-03-15       Impact factor: 2.379

  5 in total
  2 in total

1.  Electrofunctional features of the tilted disc syndrome.

Authors:  G Giuffrè; M Anastasi
Journal:  Doc Ophthalmol       Date:  1986-03-31       Impact factor: 2.379

2.  Chorioretinal degenerative changes in the tilted disc syndrome.

Authors:  G Giuffrè
Journal:  Int Ophthalmol       Date:  1991-01       Impact factor: 2.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.